Synchronous malignant rhabdoid tumor of the kidney and adrenal neuroblastoma in an infant treated with proton beam therapy: a case report and literature review

This case report and literature review presents a 4-month-old infant with a synchronous malignant rhabdoid tumor of the kidney and adrenal neuroblastoma, an exceptionally rare combination without established treatment guidelines. Following surgical resection, proton beam therapy (14 Gy in 10 fractions) was administered to the abdominal-pelvic tumor bed with stringent organ-sparing objectives. Contemporary literature supports proton beam therapy's (PBT's) dosimetric advantages for organ preservation in pediatric abdominal malignancies. At 1-year follow-up, the patient remained disease-free, with preserved renal function and normal skeletal development, supporting PBT's role in minimizing late effects while achieving local control in infant malignancies when conventional photon radiotherapy would pose substantial developmental risks.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-02-05
DOI
https://doi.org/10.3389/fonc.2025.1699028
Primary Topic
Neuroblastoma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Synchronous malignant rhabdoid tumor of the kidney and adrenal neuroblastoma in an infant treated with proton beam therapy: a case report and literature review

Ping Lu, Shosei Shimizu, Jie Wang, D.C. Meng et al.
Frontiers in Oncology
Neuroblastoma Research and Treatments
article

Synchronous malignant rhabdoid tumor of the kidney and adrenal neuroblastoma in an infant treated with proton beam therapy: a case report and literature review

Ping Lu, Shosei Shimizu, Jie Wang, D.C. Meng, Junlei Shi, Wei Han, Jargal Tumendemberel, Jie Zheng, Nan Zhang, Huaida Teng, Xinan Liu
article en

Abstract

This case report and literature review presents a 4-month-old infant with a synchronous malignant rhabdoid tumor of the kidney and adrenal neuroblastoma, an exceptionally rare combination without established treatment guidelines. Following surgical resection, proton beam therapy (14 Gy in 10 fractions) was administered to the abdominal-pelvic tumor bed with stringent organ-sparing objectives. Contemporary literature supports proton beam therapy's (PBT's) dosimetric advantages for organ preservation in pediatric abdominal malignancies. At 1-year follow-up, the patient remained disease-free, with preserved renal function and normal skeletal development, supporting PBT's role in minimizing late effects while achieving local control in infant malignancies when conventional photon radiotherapy would pose substantial developmental risks.

Frontiers in OncologyVol. 15
University of Tsukuba (JP), Guizhou Cancer Hospital (CN), Beijing Children’s Hospital (CN)
Good health and well-being
Openalex Percentile: Top 66%
Neuroblastoma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.